Clinical trial
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol)…
NCT00261482 · Janssen Pharmaceutica N.V., Belgium, Industry · Completed
Key facts
| NCT number | NCT00261482 |
|---|---|
| Title | Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception. |
| Official title | An Open Label, Multicentre Study of the EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch in Europe: Evaluation of Women's Experience With EVRA and Comparison With Previously Used Methods of Contraception. |
| Lead sponsor | Janssen Pharmaceutica N.V., Belgium, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Contraception, Female Contraception |
| Intervention type | Drug |
| Interventions | norelgestromin + ethinyl estradiol |
| Enrollment | 778 |
| Start date | Jul 1, 2003 |
| Completion | Dec 1, 2004 |
| First posted | Dec 5, 2005 |
| Last update posted | Nov 16, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: